5-((4-Ethylpiperazin-1-yl)methyl)pyridin-2-amine hydrochloride → 8-(3-Methoxy-2,5-dimethyl-phenyl)-quinoxaline-5-carboxylic acid [5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-amide
Reaktionsgleichung
[CH3:1][O:2][C:3]1[C:4]([CH3:23])=[C:5]([C:10]2[C:19]3[N:18]=[CH:17][CH:16]=[N:15][C:14]=3[C:13]([C:20](O)=[O:21])=[CH:12][CH:11]=2)[CH:6]=[C:7]([CH3:9])[CH:8]=1.Cl.[CH2:25]([N:27]1[CH2:32][CH2:31][N:30]([CH2:33][C:34]2[CH:35]=[CH:36][C:37]([NH2:40])=[N:38][CH:39]=2)[CH2:29][CH2:28]1)[CH3:26]>>[CH2:25]([N:27]1[CH2:28][CH2:29][N:30]([CH2:33][C:34]2[CH:35]=[CH:36][C:37]([NH:40][C:20]([C:13]3[C:14]4[N:15]=[CH:16][CH:17]=[N:18][C:19]=4[C:10]([C:5]4[CH:6]=[C:7]([CH3:9])[CH:8]=[C:3]([O:2][CH3:1])[C:4]=4[CH3:23])=[CH:11][CH:12]=3)=[O:21])=[N:38][CH:39]=2)[CH2:31][CH2:32]1)[CH3:26]Komponenten
3
Versuchsvorschrift
The title compound was prepared in analogy to the procedure described in Step 14.1 but using 8-(3-methoxy-2,5-dimethyl-phenyl)-quinoxaline-5-carboxylic acid (Step 97.1), 5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-ylamine hydrochloride (Step 26.1) and stirring the reaction mixture for 24 h at rt. The crude product was purified by silica gel column chromatography (DCM/MeOH/NH3aq, 94:5:1). Title compound: ESI-MS: 511.1 [M+H]+; tR=3.75 min (System 1); TLC: Rf=0.29 (DCM/MeOH/NH3aq, 94:5:1).